Literature DB >> 1419337

[The focal brain ischemia with disturbance of venous drainage].

K Miyamoto1, S Tsujimoto, M Tominaga, T Takeshima, T Morimoto, S Tsunoda, T Sakaki.   

Abstract

The focal brain ischemia with disturbance of cerebral venous drainage often lead to brain edema and hemorrhagic infarction and make mortality and morbidity worse. So we tried to make sure of this fact using a middle cerebral artery (MCA) occlusion model in adult cat. The MCA was exposed by the transorbital approach and temporally obstructed by Zen's clip. We divided the animals into two groups of eight cats. One group is only MCA occlusion group (sham group) and the other in MCA occlusion with disturbance of venous drainage (VRD group). We ligated bilateral external jugular vein (EJV) and internal jugular vein (IJV) and injected embolic sources from the left EJV to obstruct the venous system of cat brain. The pressure of superior sagittal sinus was increased up to 18.7 +/- 5.3 mmHg by this method. A cranial window was made above the ectosylvian gyrus, which has poor anastomosis. The reactivity of pial arteriole and regional cerebral blood flow (rCBF) were observed through the window. And histological brain examination was also performed. The result was that the reactivity of pial arterioles was severely disturbed in VRD group. The area of cerebral infarction and edema were also significantly expanded in VRD group. Considering from these facts, when the venous drainage was disturbed, cerebral perfusion pressure relatively decrease. Because of the decrease in cerebral perfusion pressure, cerebral infarction and edema probably expand to the area so called penumbra.

Entities:  

Mesh:

Year:  1992        PMID: 1419337

Source DB:  PubMed          Journal:  No To Shinkei        ISSN: 0006-8969


  1 in total

Review 1.  Venous endothelial injury in central nervous system diseases.

Authors:  Jonathan S Alexander; Leonard Prouty; Ikuo Tsunoda; Chaitanya Vijay Ganta; Alireza Minagar
Journal:  BMC Med       Date:  2013-10-11       Impact factor: 8.775

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.